DrugPatentWatch Database Preview
Investigational Drug Information for Ciraparantag
Email this page to a colleague
What is the development status for investigational drug Ciraparantag?
Ciraparantag is an investigational drug.
There have been 4 clinical trials for Ciraparantag.
The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2020.
The most common disease condition in clinical trials is [disabled in preview]. The leading clinical trial sponsors are Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc., Perosphere, Inc., and [disabled in preview].
There are ten US patents protecting this investigational drug and ninety-three international patents.
Summary for Ciraparantag
| US Patents | 10 |
| International Patents | 93 |
| US Patent Applications | 30 |
| WIPO Patent Applications | 17 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2020-11-01) |
| Vendors | 12 |
Recent Clinical Trials for Ciraparantag
| Title | Sponsor | Phase |
|---|---|---|
| Study of Ciraparantag for Reversal of Anticoagulation Induced by Apixaban or Rivaroxaban in Healthy Adults | Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc. | Phase 2 |
| Phase 2 Study of Apixaban Reversal by Ciraparantag as Measured by WBCT | Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc. | Phase 2 |
| Phase 2 Study of Apixaban Reversal by Ciraparantag as Measured by WBCT | Perosphere, Inc. | Phase 2 |
Clinical Trial Summary for Ciraparantag
Top disease conditions for Ciraparantag
Top clinical trial sponsors for Ciraparantag
US Patents for Ciraparantag
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Ciraparantag | ⤷ Try it Free | Controlled release dosage form | TRIASTEK, INC. (Nanjing, CN) | ⤷ Try it Free |
| Ciraparantag | ⤷ Try it Free | Oral drug dosage forms having desired drug release profiles and uses thereof | Triastek, Inc. (Nanjing, CN) | ⤷ Try it Free |
| Ciraparantag | ⤷ Try it Free | Compartmented pharmaceutical dosage forms | Triastek, Inc. (Nanjing, CN) | ⤷ Try it Free |
| Ciraparantag | ⤷ Try it Free | Ruthenium-sphingomyelin complexes and methods for their use in the treatment of tumors | ⤷ Try it Free | |
| Ciraparantag | ⤷ Try it Free | Microfluidic chip-based, universal coagulation assay | Perosphere Technologies Inc. (Danbury, CT) | ⤷ Try it Free |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Ciraparantag
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Ciraparantag | Australia | AU2017261372 | 2036-05-05 | ⤷ Try it Free |
| Ciraparantag | Canada | CA3023278 | 2036-05-05 | ⤷ Try it Free |
| Ciraparantag | China | CN107847398 | 2036-05-05 | ⤷ Try it Free |
| Ciraparantag | European Patent Office | EP3452003 | 2036-05-05 | ⤷ Try it Free |
| Ciraparantag | Hong Kong | HK1249728 | 2036-05-05 | ⤷ Try it Free |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
